Skip to main content
Signal8

Brakewood Harold Eugene

SEC insider (Form 3/4/5 filer). CIK 0001969578. Chief Business Officer at Immuneering Corp (IMRX). 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 3, 2026. Located in CAMBRIDGE, MA.

Companies Brakewood Harold Eugene has filed insider reports for

  • Immuneering Corp (IMRX): Officer, Chief Business Officer
Brakewood Harold Eugene profile photo

Brakewood Harold Eugene

CIK: 0001969578

Transaction Breakdown

Open Market Buys (P)2 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Immuneering Corp logo
IMRX

Immuneering Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Feb 3, 2026
    Award

    Stock Option

    Direct
    140K shares-
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Jan 16, 2026
    Purchase
    Direct
    5.3K shares at avg. $4.76$25K
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Jun 20, 2025
    Purchase
    Direct
    1.9K shares at avg. $2.53$5K
  • Immuneering Corp logo
    IMRX

    Immuneering Corp

    Feb 5, 2025
    Award

    Stock Option

    Direct
    100K shares-

1-4 of 4